Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation.
Vallet N, Le Grand S, Bondeelle L, Hoareau B, Corneau A, Bouteiller D, Tournier S, Derivry L, Bohineust A, Tourret M, Gibert D, Mayeur E, Itzykson R, Pacchiardi K, Ingram B, Cassonnet S, Lepage P, Peffault de Latour R, Socié G, Bergeron A, Michonneau D.
Vallet N, et al. Among authors: peffault de latour r.
Blood. 2022 Dec 8;140(23):2500-2513. doi: 10.1182/blood.2022016926.
Blood. 2022.
PMID: 35984904
Free article.
Clinical Trial.